Clinical Trial Update: Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of a regular diet as the first meal after gynecologic cancer surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Snippet

Sponsor: Chiang Mai University | Conditions: Gynecologic Neoplasms | Phase 3 | Status: WITHDRAWN